Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 4669-4676, December 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Egorin, M. J.
Right arrow Articles by Bachur, N. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egorin, M. J.
Right arrow Articles by Bachur, N. R.

Cytofluorescence Localization of Anthracycline Antibiotics

Merrill J. Egorin1, Ronald E. Clawson, Jeffery L. Cohen, Louis A. Ross and Nicholas R. Bachur

Laboratory of Clinical Biochemistry, Baltimore Cancer Research Program, Division of Cancer Treatment, National Cancer Institute, Baltimore, Maryland 21201

Previous fluorescence microscopic studies have shown daunorubicin (DNR) and Adriamycin (ADR) are localized in cell nuclei, whereas trifluoroacetyladriamycin-14-valerate is localized in the cytoplasm. Using cultured cells, we correlated structural characteristics of a series of anthracycline antibiotics with cellular disposition and metabolic response. When observed under fluorescence microscopy, DNR, ADR, N,N-dimethyldaunorubicin, N,N-dimethyladriamycin, and 4'-epiadriamycin localized in cell nuclei. When observed under fluorescence microscopy, N-acetyl daunorubicin, N,N-dibenzyldaunorubicin, 3',4'-diacetyldeaminodaunorubicin, NSC 200681, triferric ADR, aclacinomycin A, marcellomycin, musettamycin, carminomycin, 4-demethoxydaunorubicin, nogalamycin, nogamycin, and 7-con- and 7-dis-O-methyl nogarol were localized in the cytoplasm. 3'-Deaminodaunorubicin, N-formyladriamycin, and 13-aminodaunorubicin were observed in both nucleus and cytoplasm. Therefore, alterations at ring positions 4 and 9 and on the glycoside amino group were critical in determining intracellular drug localization as assessed by fluorescence microscopy. Total cellular drug accumulation was not related to microscopically determined intracellular location. For nuclearly localized drugs, accumulation of N,N-dimethyldaunorubicin > N,N-dimethyladriamycin > DNR > 4'-epiadriamycin > ADR. For cytoplasmically and nonspecifically localized compounds, accumulation of musettamycin > carminomycin > 7-con-O-methyl nogarol > 4-demethoxy-daunorubicin > NSC 200681 > marcellomycin > aclacinomycin A > nogalamycin = 13-aminoadriamycin > nogamycin > 7-dis-O-methyl nogarol > N-formyldaunorubicin > N-acetyldaunorubicin. The accumulation of these drugs by isolated L1210 cell nuclei did not correlate with their cellular accumulation or cytofluorescence localization. Although the compounds the fluorescence of which was most severely quenched by DNA, RNA, or isolated L1210 nuclei were among those localized by microscopy to the cytoplasm, the quenching of many cytoplasmic drugs was comparable to that of nuclear ones. Both nuclear and cytoplasmically localized drugs inhibited L1210 cell [3H]thymidine and [3H]uridine incorporation without relationship to intracellular disposition or total accumulation. Thus, modification of specific sites on the anthracycline molecule are correlated with intracellular drug localization as defined by fluorescence microscopy, but the effects of these modifications on other aspects of drug accumulation and cell macromolecular biosynthesis are much less predictable.

1 To whom requests for reprints should be addressed.

Received 3/10/80. Accepted 9/12/80.




This article has been cited by other articles:


Home page
J. Histochem. Cytochem.Home page
K. Fujiwara, H. Takatsu, and K. Tsukamoto
Immunocytochemistry for Drugs Containing an Aliphatic Primary Amino Group in the Molecule, Anticancer Antibiotic Daunomycin as a Model
J. Histochem. Cytochem., April 1, 2005; 53(4): 467 - 474.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.